Browse 1,492 gastrointestinal clinical trials enrolling across the United States and Canada. 173 people applied to gastrointestinal studies last month. Search by city or state to find one near you.
Filter
1
Filter results
Results: 1,492
Active & Responsive
Fecal Microbiota Transplantation for IBS
for
Irritable Bowel Syndrome, Diarrhea
Location: Rochester MN
Sponsor: Madhusudan (Madhu) Grover, MBBS
Sex: Female
Age: 18 - 70
Code: NCT05776914
Phase 2, Recruiting
Active & Responsive
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
for
Metastatic Colorectal Cancer
Location: Port Jefferson Station NY, New Haven CT,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT04929223
Phase 1, Recruiting
Active & Responsive
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
for
Colorectal Cancer, Advanced Adenocarcinoma
Location: Raonoke VA
Sponsor: Universal Diagnostics
Sex: All
Age: 45 - 70+
Code: NCT06059963
Recruiting
Active & Responsive
Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
for
Gastric Antral Vascular Ectasia, Cirrhosis,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 19+
Code: NCT06306963
Recruiting
Active & Responsive
The Cancer of the Pancreas Screening-5 CAPS5)Study
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT02000089
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Screening Women With Prior HPV for Anal Neoplasia
for
HPV-related Lower Genital Tract Neoplasias,
Location: New York NY, Charleston SC, Houston TX
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: Female
Age: 35+
Code: NCT05217940
Recruiting
Active & Responsive
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
for
Hereditary Hemorrhagic Telangiectasia,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Cure HHT
Sex: All
Age: 0+
Code: NCT06259292
Recruiting
Active & Responsive
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
for
Esophageal Adenocarcinoma, Gastric Adenocarcinoma
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT04150640
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
for
Esophageal Squamous Cell Carcinoma
Location: East Syracuse NY, Pittsburgh PA, Tucson AZ,